Recent findings suggest that peptide fragments of newly synthesized proteins may associate intracellularly with nascent chains of class I histocompatibility antigens (termed MHC-I proteins because they are encoded by genes of the major histocompatibility complex) and that these peptide adducts may be required for the folding or stability and perhaps even the transport of these proteins to the cell surface. To determine whether these proteins can be reconstituted from their separated subunits into ostensibly native molecules in the absence of added peptides, we denatured a purified human MHC-I protein (HLA-A2) with 4 M NaSCN, separated its heavy (a) and light (p2-microglobulin) chains by gel filtration, and then mixed them in the presence of a 3-fold molar excess of (32-microglobulin and absence of added peptides. The reconstituted protein, recovered in 10% yield, was indistinguishable from native A2 in its reactivity with a monoclonal antibody (BB7.7) and its ability to specifically activate A2-specific CD8+ T cells. Inasmuch as the reconstituted A2 contained no detectable peptideidducts (we estimate <1 per 100 on a molar basis, assuming peptides of 2-5 kDa), the results suggest that peptidefree A2 can be recognized by CD8+ T cells and that peptide adducts are not essential for the MHC-I protein to maintain an ostensibly native structure.
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Considerable evidence suggests that the antigenic structures recognized on target cells by CD8+ cytotoxic T lymphocytes (CTLs) are binary complexes formed by the association of peptide fragments of protein antigens with class I histocompatibility antigens (encoded in the major histocompatibility complex and termed MHC-I proteins). How and when peptide fragments become associated with MHC-I proteins, and what proportion of the MHC-I molecules on a cell's surface are associated with peptides, are unresolved questions. However, x-ray crystallographic analysis of a human MHC-I protein (HLA-A2) has suggested that virtually all of the peptide binding sites on the purified protein are occupied by peptides (1) . Moreover , it has been observed that an MHC-I protein which was synthesized but not expressed on the surface ofa mutant cell line could be induced to appear on the cell surface simply by incubating the cells with a peptide that associates with that MHC-I protein (2) . This finding has raised the possibilities that peptide fragments of newly formed proteins might normally become associated intracellularly with nascent MHC-I polypeptide chains as they fold into mature MHC-I molecules and that the peptide adducts may even be required for the folding and stability of class I MHC molecules and for their ultimate transport to the cell surface.
To help evaluate those possibilities, it would be useful to know whether or not the constituent heavy and light chains of an MHC-I protein can be separated and then reassociated in the absence of added peptides to form stable, native protein molecules. In an earlier attempt to meet this objective, it was found that when the subunits of HLA-A2 were separated in a denaturing solvent they could reassociate after the denaturing solvent was removed, but not if the subunits were first separated from each other-e.g., by gel filtration (3) 
MATERIALS AND METHODS
Purification of HLA-A2. HLA-A2 was isolated as described (4) Competitive Immune Cytolysis Assay. A2 and renatured A2 were assayed for their ability to inhibit immune cytolysis of 51Cr-labeled JY cells (A2,2; B7,7) by a cytotoxic monoclonal antibody, BB7.7, as described (4). Percent specific lysis was calculated as 100(a -b)/(c -b), where a is experimentally released 51Cr, b is spontaneously released 51Cr (i.e., in absence of antibody and complement), and c is the total amount of 51Cr released by adding Nonidet P-40 (0.25%) to the labeled cells. Nonspecific lysis by complement in the absence of antibody was always <2% of c. Results are expressed as the percent inhibition of maximum lysis, which is defined as percent specific lysis in the absence of inhibitor.
SDS/PAGE and Autoradiography. SDS/PAGE was performed using 18% acrylamide gels containing 6 M urea (5) . Gels were stained with silver (6) or with Coomassie brilliant blue R (Sigma). Samples containing 4 M NaSCN were desalted using disposable reverse-phase C18 cartridges (SepPak; Waters). Where appropriate, SDS/polyacrylamide gels were dried onto Whatman 3MM chromatography paper and exposed to Kodak X-Omat AR x-ray film for 24-72 hr.
Todination. Samples in phosphate-buffered saline [PBS: 10 mM sodium, potassium phosphate (pH 7.4) containing 150
mM NaCl] were radioiodinated with 1 mCi (37 MBq) of carrier-free Na125I in the presence of solid-phase N-chlorobenzenesulfonamide (lodo-Beads; Pierce) (7).
CTLs. A human alloreactive CTL line (termed A2p) specific for HLA-A2 was originally isolated from a mixed lymphocyte culture of JY lymphoblastoid stimulator cells (A2,2; B7,7; DR4,6) and peripheral blood mononuclear cells from donor HNE (A1,3; B35,38; DR4,6; DQwl,w3) by their adsorption to purified A2 that was adsorbed onto plastic dishes (8) . Cultured A2p cells were CD8+ and highly cytolytic for A2+ cells.
T-Cell Activation Assay. Sterile flat-bottomed 96-well tissue culture plates (Costar) were coated with native, renatured, or denatured HLA-A2 or with monoclonal antibody OKT3 in PBS overnight at 4°C. Unadsorbed A2 was removed and wells were "blocked" with PBS containing 1% bovine serum albumin. Stationary-phase A2p cells (2 x 105 per well) in serum-free medium (AIM V; GIBCO) containing interleukin 2 (IL-2, 20 units/ml) were added and the plates were incubated at 37°C in a 5% CO2 atmosphere. When JY cells were used as stimulators in lieu of adsorbed A2, 3.3 X 104 irradiated (6000 rads; 1 rad = 0.01 Gy) cells in AIM V (with recombinant IL-2 at 20 units/ml) were added per culture. (Fig. lb) and the leading edge (lane d) and trailing edge (lane e) of peak III (Fig. lb) . Lanes a-e were silver-stained. Samples of peaks VI, VII, and VIII ( Fig. 1 c and d) were run in lanes f, g, and h, respectively, and protein was detected by Coomassie blue. Molecular mass markers (kDa) are shown to the left of lanes a and f. excess of 832m over the a chain. Excess 82m was added to drive the renaturation equilibrium in the direction of a/,32m heterodimer formation. After removal of NaSCN, the final mixture was analyzed by gel filtration (Fig. ic) . Two peaks were evident: one (peak VI) corresponding to the a/f82m heterodimer and the other (peak VII) to free f32m (see Fig. 2 , lane f for peak VI and lane g for peak VII). The identity of the first peak (VI) was verified by a further gel filtration run, which resulted in a monodisperse preparation consisting of a/,32m heterodimers (peak VIII, Fig. ld and Fig. 2, lane h) .
The latter represents reassociated A2 and is expected to be virtually free of peptide adduct, since material of <10 kDa was removed following denaturation (Fig. lb) and was absent during the renaturation process. In other preparations low molecular mass material was removed in the continuous presence of NaSCN by membrane filtration, which proved to be as effective as gel filtration.
The average yield of renatured a chains from eight such experiments was 10 ± 1.9%. When excess 2m was omitted from the renaturation mixture, the average yield fell to below 2%.
To address the possibility that some a chain may have retained its peptide adduct through the denaturation procedure, we determined the sensitivity of the silver-stain technique used to analyze a chain by SDS/PAGE. We could detect as little as 1-5 ng of a peptide in the molecular mass range 2.5-16 kDa. Since 5-10 ,ug of a chain was applied to lane b of Fig. 2 , and no silver-stained material was observed in the range 2-15 kDa, it appeared that peptide was present at <1 part per 1000-10,000 by weight or less than around 1 per 100-1000 in molar terms (for a peptide of 3.5 kDa).
The two minor peaks that appeared reproducibly following denaturation (peaks IV and V in Fig. lb) could have represented the electron-dense material seen in the crystal structure of A2, thought to be specifically bound peptides (1). Buus et al. (9) reported the release of low molecular mass material denatured from I-Ad; though too little was recovered to be characterized chemically, it contained immunologically active peptides by bioassay. Accordingly, we radiolabeled with 121I the low molecular mass material released from 250 ,g of A2 following denaturation in 4 M NaSCN (Fig. lb , peaks IV and V). The radiolabeled material was analyzed by SDS/PAGE followed by autoradiography. Fig. 3 , lane a, clearly shows a band migrating at -2 kDa; also evident is some 82m (12 kDa), which passed through the membrane used to separate high and low molecular mass material (see Materials and Methods). The low molecular mass material was separable from f32m on a Sephadex G-50 column (Fig. 3 , lane b), and it was eliminated by incubating it overnight at 370C with either trypsin at pH 7.3 or pepsin at pH 2.5, indicating that it was peptide in nature. It was not released from A2 when NaSCN was replaced by PBS in a mock denaturation (Fig. 3, lane c) ; it is especially notable that it was not detected when renatured A2 was itself denatured in 4 M NaSCN and fractionated by membrane filtration (Fig. 3 Fig. 1c (m) , and purified renatured A2 corresponding to peak VIII of Fig. 1 (C) . In both a and b, the maximum response was 42% specific lysis of JY.
with purified, papain-solubilized native A2, but not when coated with denatured A2 (8) .
To determine whether these CTLs could recognize renatured A2 adsorbed to plastic plates, we used [3H]thymidine incorporation to measure their specific activation. For this purpose, A2p cells were cultured in the presence of recombinant IL-2 in 0.5-cm tissue culture wells that had been coated with either native A2, renatured A2, or A2 that had been denatured by reduction and alkylation with iodoacetamide. In addition, as positive controls, cultures were set up in wells coated with a monoclonal antibody (OKT3) to the CD3 component of the T-cell antigen-specific receptor complex. Proliferative responses were detected on day 2 and day 6 and were maximal on day 4. Fig. 5 shows dose-dependent responses of A2p cells that had been incubated for 4 days in microtiter wells coated with various concentrations of OKT3, native A2, and renatured A2. The maximum stimulation index observed with OKT3 was 4.4 in the experiment shown; in other experiments, using different preparations of OKT3, responses up to 27.0 were seen. The responses to renatured A2 and native A2 were indistinguishable at all coating concentrations tested. No response was elicited by ovalbumin or by denatured A2. The natural targets for A2p cells, JY cells, were also tested as a source of stimulation at a CTL/target cell ratio of 3:1 (chosen to provide roughly the same number of A2 molecules per culture as wells coated with 50 A.l of A2 at 5 pug/ml, assuming a coating efficiency of 0.1%). On day 4, the stimulation index for A2p cells cultured with irradiated (6000 rads) JY cells was 4.1 ± 0.1 after correction of the [3H]thymidine incorporation for uptake by target cells alone. Thus, under the experimental conditions used, renatured A2 and native A2 were approximately as effective as JY cells in stimulating A2p cells. In all cases, the proliferative response was found to be dependent on the addition of IL-2.
Although the observed dose-responses of A2p cells to native A2 and renatured A2 were indistinguishable, it was possible that some CTLs responded only to renatured A2 and others only to native A2. To test this possibility, two 100-fold dilutions of a mixture of native A2 and renatured A2, each at 50 ,ug/ml, were used to coat wells. If the observed responses were due to separate populations of CTLs, at each dilution the response to the mixture would approximate the sum of the responses to the individual components, and this effect would be especially notable at concentrations that gave maximal responses when either protein was used alone. Fig. 5 shows that this was not the case: the A2p cells' response to the mixture was similar to their response to native A2 or renatured A2 individually, indicating that the same cells responded equally well to both forms of A2.
DISCUSSION
In this study we have shown that it is possible to dissociate the A2 heavy (a) and light (J2m) chains in the presence of a (2) , who suggested that acf3 assembly and transport to the cell surface in vivo are dependent upon bound peptide. They do not, however, preclude the possibility that a/3 assembly can be driven in vitro by the addition of excess f32m in the absence of peptide. Indeed, we, and others (3), have been unable to renature HLA-A2 in the absence of excess 832m. The ability to prepare renatured A2 that is ostensibly peptidefree enabled us to address the central question of allorecognition-i.e., whether CTLs that react specifically with allogeneic MHC-I proteins recognize peptide/MHC complexes or MHC molecules alone.
According to a modem version (11) of a hypothesis advanced about 12 years ago by Matzinger and Bevan (12) , under physiologic conditions any particular MHC-I protein on a cell's surface exists as a highly heterogeneous population of binary complexes, each formed with one of the many peptides arising in that cell as a result of proteolytic degradation of newly synthesized cellular protein. Accordingly, an alloreactive T cell that is nominally specific for a particular MHC-I protein actually recognizes only one or a few of the multitude of different complexes formed by various peptides with that MHC-I protein on the target cell surface. The multitude of different complexes formed by a particular MHC-I protein could be recognized by many different T-cell clones.
However, it is also possible that a T cell can recognize an allogeneic MHC-I protein alone, and that the role of associated peptide adducts is to maintain the MHC-I molecule in a native conformation. Another possibility is that alloreactive T cells can recognize MHC-I molecules having no associated adducts-i.e., as "naked" molecules-even though MHC-I protein often exists as complexes with peptides. According to this possibility every molecule of an MHC-I protein encoded by the appropriate allele could be a ligand for alloreactive CTLs that are specific for that MHC-I protein (the determinant-density hypothesis, refs. 13 and 14) .
Our experiments showed that renatured A2, judged to be free from peptide adducts (by the absence of releasable low molecular mass material following a second round of denaturation; Fig. 3, lane d) , was as effective as native A2 in stimulating anti-A2 CTLs. Hence peptides appear not to be essential for allorecognition, at least for a subset of alloreactive CTLs. Moreover, under the experimental conditions used, both forms of A2 were as effective in stimulating A2p cells as was the "natural" ligand on the surface of JY cells, where it is indeed possible that a majority of A2 molecules contain bound peptides. Although the results obtained with intact JY cells and with purified A2 adsorbed on plastic are difficult to compare, they suggest that the presence of bound peptide in the natural MHC-I ligand neither ablates nor enhances its recognition by A2p cells.
The A2p cells were originally isolated from a mixed lymphocyte reaction according to their ability to recognize and respond to purified soluble A2 adsorbed to plastic (8) . It is thus possible that A2p cells represent a subpopulation of alloreactive CTLs having an unusually high capacity to recognize determinants on A2 alone. This possibility is supported by the observation that not all anti-A2 alloreactivity was removed from the mixed lymphocyte culture when A2p cells were originally isolated by adsorbing ("panning") them on A2 (8) .
An alternative explanation of our results is that the 10% of renatured HLA-A2 molecules recovered represented a population of a chains that had not released bound peptides during incubation with 4 M NaSCN, despite the effect of the denaturant in causing this chain and the f32m subunit to dissociate: thus the recovered renatured A2 molecules would be expected to be enriched with nondissociating peptides. We think that this possibility is unlikely, since when a chains used for renaturation were heated to 100TC in the presence of 0.1% SDS and then analyzed by PAGE, no low molecular mass material could be visualized in a 5-to 10-,ug sample of renatured A2 with a sensitive silver staining technique that was capable of visualizing 1-5 ng of a homogeneous peptide of 2-16 kDa. This result suggests that any single retained peptide present as a contaminant in the a-chain preparations would have been present at a level below around 1 mol of peptide per 100-1000 mol of a chains (see Results). Moreover, if retained peptides were relevant for the specific response of CTLs to renatured A2, they would have to have been selectively retained (while other peptides were selectively lost), since the CTLs responded equally well to renatured A2 and native A2. Such a fortuitous selective retention seems implausible. Therefore, we believe our results support the determinant-density model of alloreactivity.
Though we here emphasize differences between the two models, it should be noted that they are not, of course, mutually exclusive; the ligands for some alloreactive CTLs might be binary MHC/peptide complexes (e.g., ref. 15) , while for others they might be an MHC protein alone, regardless of whether or not it is complexed with peptide. Panning ofalloreactive CTLs (in a mixed lymphocyte culture) on purified, adduct-free MHC-I protein, and on the same protein having the appropriate peptide adducts, may help determine which type of allorecognition is the more common.
